Wim Van Paesschen

Professor in Neurology

Country flagBelgium

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

According to the International League Against Epilepsy classification, mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is considered an epilepsy syndrome. Several etiologies may precede HS, but there is little overview in the literature about these etiologies. We conducted a scoping review to systematically search, select, analyze, and synthesize the existing knowledge about the etiology of HS in patients with epilepsy. MEDLINE, Embase, Web of Science Core Collection, and Cochrane Library were searched using a systematic search strategy. Relevant data were selected according to strict criteria. A bibliometric analysis was done by VOSviewer software. A total of 907 studies were selected and classified. The main classes of etiologies we found are prolonged (febrile) seizures, genetic predisposition, infection, autoimmunity, trauma, neurodegeneration, developmental aspects, toxins (e.g., domoic acid), and hypertensive events (e.g., Posterior reversible encephalopathy syndrome), with several interactions between different etiologies. Autoimmunity and neurodegeneration were the most recently described etiologies. We found that the etiology of MTLE‐HS is complex, with several risk factors influencing susceptibility and a heterogenous pathophysiology between patients. Future, prospective studies addressing the interactions of these etiologies in the development of HS are warranted. A better understanding of the interacting etiologies of MTLE‐HS could have a major impact on the development of more precise diagnostic biomarkers, preventive strategies, and treatment options for this epilepsy syndrome.

Year:

2025

Automated sleep staging on wearable data could improve our understanding and management of epilepsy. This study evaluated sleep scoring by a deep learning model on 223 night‐sleep recordings from 50 patients measured in the hospital with an electroencephalogram (EEG) and a wearable device. The model scored the sleep stage of every 30‐s epoch on the EEG and wearable data, and we compared the output with a clinical expert on 20 nights, each for a different patient. The Bland–Altman analysis examined differences in the automated staging in both modalities, and using mixed‐effect models, we explored sleep differences between patients with and without seizures. Overall, we found moderate accuracy and Cohen's kappa on the model scoring of standard EEG (0.73 and 0.59) and the wearable (0.61 and 0.43) versus the clinical expert. F1 scores also varied between patients and the modalities. The sensitivity varied by sleep stage and was very low for stage N1. Moreover, sleep staging on the wearable data underestimated the duration of most sleep macrostructure parameters except N2. On the other hand, patients with seizures during the hospital admission slept more each night (6.37, 95% confidence interval [CI] 5.86–7.87) compared with patients without seizures (5.68, 95% CI 5.24–6.13), p = 0.001, but also spent more time in stage N2. In conclusion, wearable EEG and accelerometry could monitor sleep in patients with epilepsy, and our approach can help automate the analysis. However, further steps are essential to improve the model performance before clinical implementation. Trial Registration: The SeizeIT2 trial was registered in clinicaltrials.gov, NCT04284072

Year:

2025

Objective Typical absence seizures are underreported. We aimed to improve patient care using a wearable electroencephalograph (wEEG) at home and assess a machine learning (ML) pipeline for absence detection. Methods Patients with typical absences used a wEEG device 12–24 h 1 week after antiseizure medication (ASM) adjustments. Three‐hertz generalized spike–wave discharges (SWDs) ≥ 3 s were used as absence surrogates. After manual inspection, we used the results to guide medical treatment. The outcomes were seizure freedom, number of consecutive measurements without relapse, and side effects. Afterward, we used the ML pipeline on the recordings, and a neurologist reviewed the output. Review time and diagnostic performance were compared with manual inspection. Results Nineteen patients (12 female, median age = 24 years) were followed for a median of 5 months (range = 1–12). The median recording time for each session was 21.3 h (range = 10–24). Fifteen patients (79%) were seizure‐free during the last measurement, including seven of 11 (63%) diagnosed with refractory epilepsy. Ten patients relapsed after a median of 1–2 recordings (range = 1–6) without 3‐Hz SWDs. Side effects occurred in 21% of patients. Manual file inspection identified 806 3‐Hz SWDs of ≥3 s. The ML pipeline reduced a neurologist's median review time for 24‐h wEEG from 27 (range = 10–45) to 4.3 min (range = .1–10), with a sensitivity, precision, F1‐score, and false positives per hour of .8, .95, .87, and .007, respectively. Significance Home‐based wEEG allows patient monitoring after ASM adjustments, improving absence seizure management. The ML‐based pipeline performed well and was crucial in reducing review time.

Year:

2025

Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”

Year:

2024

Long-term home monitoring of people living with epilepsy cannot be achieved using the standard full-scalp electroencephalography (EEG) coupled with video. Wearable seizure detection devices, such as behind-the-ear EEG (bte-EEG), offer an unobtrusive method for ambulatory follow-up of this population. Combining bte-EEG with electrocardiography (ECG) can enhance automated seizure detection performance. However, such frameworks produce high false alarm rates, making visual review necessary. This study aimed to evaluate a semi-automated multimodal wearable seizure detection framework using bte-EEG and ECG. Using the SeizeIT1 dataset of 42 patients with focal epilepsy, an automated multimodal seizure detection algorithm was used to produce seizure alarms. Two reviewers evaluated the algorithm’s detections twice: (1) using only bte-EEG data and (2) using bte-EEG, ECG, and heart rate signals. The readers achieved a mean sensitivity of 59.1% in the bte-EEG visual experiment, with a false detection rate of 6.5 false detections per day. Adding ECG resulted in a higher mean sensitivity (62.2%) and a largely reduced false detection rate (mean of 2.4 false detections per day), as well as an increased inter-rater agreement. The multimodal framework allows for efficient review time, making it beneficial for both clinicians and patients.

Year:

2023

Collaborators (26)

Tim Schedl

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Pamela Trapane

Professor and Chief, Division of Pediatric Genetics

University of Florida College of Medicine - Jacksonville

UNITED STATES
View details

Anna Jansen

University of Antwerp

BELGIUM
View details

Carol Saunders

Children's Mercy Hospital

UNITED STATES
View details

Olaf Riess

University of Tuebingen

GERMANY
View details

Andreas Roos

-

GERMANY
View details

Matthias Begemann

Medizinische Fakultät der RWTH Aachen

GERMANY
View details

Marco Tartaglia

Head

Ospedale Pediatrico Bambino Gesù

ITALY
View details

Joachim Weis

Medizinische Fakultät der RWTH Aachen

GERMANY
View details

Martin Wiesmann

University Hospital RWTH Aachen

GERMANY
View details

Andrea Ciolfi

Senior Staff Scientist

Ospedale Pediatrico Bambino Gesù

ITALY
View details

Stephen Pak

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Weimin Yuan

Staff scientist

Washington University in St. Louis

UNITED STATES
View details

Judith Frydman

Professor

Stanford University

UNITED STATES
View details

Marije Meuwissen

-

BELGIUM
View details

Micheil Innes

Associate Professor

University of Calgary

CANADA
View details

Gary A Silverman

Chair

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Renske Oegema

UMC Utrecht

NETHERLANDS
View details

Martin Häusler

Head of Division, Prof. Dr. med

RWTH Aachen University

GERMANY
View details

Gael Nicolas

PUPH

University of Rouen

FRANCE
View details

Andrea Maier

-

GERMANY
View details

Hanns Lochmüller

Senior Scientist

-

CANADA
View details

Stefan Wolking

-

GERMANY
View details

Ingo Kurth

Head of Institute

RWTH Aachen University

GERMANY
View details

Thomas Smol

PU-PH

Université de Lille

FRANCE
View details

Yvonne Weber

Leader of the Dpt. of Epileptology/ Prof

RWTH Aachen University

GERMANY
View details